| Date | Action | Conf | Host / episode | Summary | 7d | 30d | 90d |
|---|---|---|---|---|---|---|---|
| 2026-09-08 | SELL | MEDIUM | Rob Black Show Afternoon podcast 9-8-26 |
Novartis fell about 12-14% on its third clinical trial failure in a week, wiping out $20 billion, after del-desiran failed a late stage trial - the centerpiece of its $12 billion Avidity acquisition. [audio] | +0.7% | — | — |
| 2026-05-13 | MENTIONED | LOW | Rob Black Show Mixed Markets As Inflation Jumps |
Mentioned as a partner of Isomorphic Labs for cancer and immune disorder therapies. [audio] | +0.5% | +2.2% | +3.2% |